Mineral bone disorders in kidney disease patients: the ever-current topic

L Hu, A Napoletano, M Provenzano, C Garofalo… - International Journal of …, 2022 - mdpi.com
Chronic kidney disease (CKD) is a complex and multifactorial disease, and one of the most
prevalent worldwide. Chronic kidney disease–mineral bone disorders (CKD–MBD) with …

Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism

MC Hu, K Shiizaki, M Kuro-o… - Annual review of …, 2013 - annualreviews.org
The metabolically active and perpetually remodeling calcium phosphate–based
endoskeleton in terrestrial vertebrates sets the demands on whole-organism calcium and …

Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion

PP Centeno, A Herberger, HC Mun, C Tu… - Nature …, 2019 - nature.com
Extracellular phosphate regulates its own renal excretion by eliciting concentration-
dependent secretion of parathyroid hormone (PTH). However, the phosphate-sensing …

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

EVOLVE Trial Investigators - New England Journal of Medicine, 2012 - Mass Medical Soc
Background Disorders of mineral metabolism, including secondary hyperparathyroidism, are
thought to contribute to extraskeletal (including vascular) calcification among patients with …

A growth selection system for the directed evolution of amine-forming or converting enzymes

S Wu, C Xiang, Y Zhou, MSH Khan, W Liu… - Nature …, 2022 - nature.com
Fast screening of enzyme variants is crucial for tailoring biocatalysts for the asymmetric
synthesis of non-natural chiral chemicals, such as amines. However, most existing …

Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS …

F Tentori, M Wang, BA Bieber… - Clinical Journal of the …, 2015 - journals.lww.com
Results Median parathyroid hormone increased from phase 1 to phase 4 in all regions
except for Japan, where it remained stable. Prescriptions of intravenous vitamin D analogs …

Emerging paradigms in GPCR allostery: implications for drug discovery

D Wootten, A Christopoulos, PM Sexton - Nature reviews Drug …, 2013 - nature.com
Allosteric ligands bind to G protein-coupled receptors (GPCRs; also known as seven-
transmembrane receptors) at sites that are distinct from the sites to which endogenous …

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

P Raggi, GM Chertow, PU Torres… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. This prospective, randomized, controlled trial compared the progression of
vascular and cardiac valve calcification in 360 prevalent adult hemodialysis patients with …

Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) …

SM Moe, GM Chertow, PS Parfrey, Y Kubo, GA Block… - Circulation, 2015 - Am Heart Assoc
Background—Patients with kidney disease have disordered bone and mineral metabolism,
including elevated serum concentrations of fibroblast growth factor-23 (FGF23). These …

[HTML][HTML] Update on fibroblast growth factor 23 in chronic kidney disease

M Wolf - Kidney international, 2012 - Elsevier
Chronic kidney disease (CKD) is a public health epidemic that affects millions of people
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …